Pasithea TherapeuticsKTTA

13F holders, Q4 2025 (December 31)
1holders
$1.29avg. 13F price*

At the end of Q4 2025, 1 institutions reported holding Pasithea Therapeutics Corp. (KTTA) in their 13F filings. The largest holder was Magnolia Private Wealth, LLC ($43K).

Company
Pasithea Therapeutics Corp.
CUSIP
70261F103
Latest filing quarter
Q4 2025

Total Exit/New Position Q4 2025

InstitutionsTotal Value
New Positions1$43K
Exits0$0

Ownership 1 holders

Magnolia Private Wealth, LLC 0.03% New 33,333 $43K

"% of holder's portfolio" is KTTA's weight in each manager's 13F, not the share of Pasithea Therapeutics Corp. the manager owns.